{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:08:52Z","timestamp":1784891332484,"version":"3.55.0"},"reference-count":146,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T00:00:00Z","timestamp":1326844800000},"content-version":"vor","delay-in-days":5974,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1995,9,10]]},"abstract":"<jats:p>Although valproate, a simple branched\u2010chain fatty acid, is generally considered to be an antiepileptic agent, a large literature dating back to 1966 describes its use in primary psychiatric disorders. The significant role that \u03b3\u2010aminobutyric acid plays in mood provided the rationale to examine valproate in this regard. Numerous uncontrolled as well as placebo\u2010 and lithium\u2010controlled studies verified the drug's efficacy in the short\u2010term management of bipolar and schizoaffective disorders. The response appears to be independent of response to traditional therapies such as lithium, neuroleptics, and carbamazepine, and may be maintained for extended periods of time. Valproate should be considered not only in patients with mood disorders who are intolerant of or nonresponsive to traditional therapies, but also in those with rapid cycling, electroencephalographic abnormalities, head trauma antedating the onset of psychiatric illness, or any other factor suggesting an organic component. Preliminary uncontrolled studies suggest that the drug may also eventually play a role in the management of panic disorder and behavioral dyscontrol (agitation, aggression, temper outbursts). Its adverse event profile is well known from years of experience in the management of epilepsy and does not appear to be altered in the presence of psychiatric disorders. Similarly, the drug\u2010drug interaction potential of valproate is reasonably well known, although further research into interactions with psychotropic agents is warranted.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1995.tb02874.x","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T12:23:55Z","timestamp":1414499035000},"page":"631-647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Emerging Role of Valproate in Bipolar Disorder and Other Psychiatric Disorders"],"prefix":"10.1002","volume":"15","author":[{"given":"David R.P.","family":"Guay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,18]]},"reference":[{"issue":"3","key":"e_1_2_1_2_2","first-page":"17","article-title":"The scope and use of valproate in epilepsy","volume":"50","author":"Penry JK","year":"1989","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_1_3_2","first-page":"23","article-title":"Valproate in psychiatric disorders: literature review and clinical guidelines","volume":"50","author":"McElroy SL","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(86)90059-9"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00005"},{"key":"e_1_2_1_7_2","first-page":"183","volume-title":"Psychopharmacology: the third generation of progress","author":"Lloyd KG","year":"1987"},{"key":"e_1_2_1_8_2","volume-title":"GABA and mood disorders: experimental and clinical research","author":"Bartholini G.","year":"1986"},{"key":"e_1_2_1_9_2","first-page":"145","volume-title":"American Psychiatric Press review of psychiatry","author":"Potter WZ","year":"1990"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.12.1533"},{"key":"e_1_2_1_11_2","first-page":"673","volume-title":"Neurobiology of mood disorders","author":"Berrettini WH","year":"1984"},{"key":"e_1_2_1_12_2","first-page":"43","volume-title":"Use of anticonvulsants in psychiatry: recent advances","author":"Chouinard G.","year":"1987"},{"key":"e_1_2_1_13_2","first-page":"757","article-title":"Mania associated with the use of baclofen","volume":"17","author":"Wolf ME","year":"1982","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.11.1466"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770160104009"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810040059009"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(81)90169-X"},{"key":"e_1_2_1_18_2","first-page":"3","volume-title":"Anticonvulsants in affective disorders","author":"Maitre L.","year":"1984"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","article-title":"Sodium valproate, but not ethosuximide, produces use\u2010 and voltage\u2010dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"McLean MJ","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00228121"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1978.tb04504.x"},{"key":"e_1_2_1_22_2","unstructured":"WaldenJ. AltrupU. ReithH. SpeckmannEJ.Valproate induced increase of transmembranous potassium currents.Presented at the World Congress of Biological Psychiatry 1991."},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90078-A"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90396-9"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90429-A"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(12)80216-6"},{"key":"e_1_2_1_27_2","first-page":"831","article-title":"Classification of affective disorders","volume":"47","author":"Ramana R.","year":"1992","journal-title":"Br J Hosp Med"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/clinchem\/40.2.303","article-title":"Brain mechanisms in manic depression","volume":"40","author":"Carroll BJ.","year":"1994","journal-title":"Clin Chem"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.11.1473"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.11.1149"},{"key":"e_1_2_1_31_2","first-page":"409","article-title":"NIMH workshop report on treatment of bipolar disorder","volume":"26","author":"Prien RF","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199107001-00008"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000118980"},{"key":"e_1_2_1_34_2","first-page":"115","article-title":"Psychotic affective disorders: assessment and treatment issues","volume":"9","author":"Janicak PG","year":"1991","journal-title":"Psychiatr Med"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199308000-00003"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.11.1227"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379203700507"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700001975"},{"key":"e_1_2_1_39_2","first-page":"727","article-title":"Manic\u2010depressive disorder","volume":"236","author":"Eccleston D.","year":"1992","journal-title":"Practitioner"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00002"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01064926"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30159-X"},{"key":"e_1_2_1_43_2","first-page":"37","article-title":"Treatment of rapid cycling bipolar illness","volume":"26","author":"Post RM","year":"1990","journal-title":"Psycho-pharmacol Bull"},{"key":"e_1_2_1_44_2","first-page":"33","volume-title":"Anticonvulsants in affective disorders","author":"Lambert PA.","year":"1984"},{"key":"e_1_2_1_45_2","first-page":"458","article-title":"Etude clinique de l'effet normothymique du dipropylacetamide","volume":"76","author":"Semadeni GW.","year":"1967","journal-title":"Acta Psychiatr Belg"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(85)90022-9"},{"key":"e_1_2_1_47_2","first-page":"56","volume-title":"Anticonvulsants in affective disorders","author":"Brennan MJW","year":"1984"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(84)90013-2"},{"key":"e_1_2_1_49_2","first-page":"223","article-title":"Comparison of side effects of lithium and dipropylacetamide (Depamide)","volume":"4","author":"Vencovsky E.","year":"1983","journal-title":"Cesk Psychiatr"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198408000-00002"},{"key":"e_1_2_1_51_2","first-page":"6","article-title":"The role of sodium valproate as an anti\u2010manic agent","volume":"4","author":"Prasad AJ.","year":"1984","journal-title":"Pharmatherapeutica"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90320-3"},{"key":"e_1_2_1_53_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0767399X00001851","article-title":"Treatment of psychiatric disorders with valproate: a series of 73 cases","volume":"3","author":"McElroy SL","year":"1988","journal-title":"Psychiatr Psychobiol"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199402000-00009"},{"key":"e_1_2_1_55_2","first-page":"276","article-title":"Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature","volume":"12","author":"Ketter TA","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_56_2","first-page":"479","article-title":"Valproate use in the older manic patient","volume":"51","author":"McFarland BH","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.1.108"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379303800213"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379203700812"},{"key":"e_1_2_1_60_2","first-page":"213","article-title":"Divalproex sodium treatment in late adolescent and young adult acute mania","volume":"29","author":"Papatheodorou G.","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199004000-00032"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879400700110"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.4.3.319"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199203000-00014"},{"key":"e_1_2_1_65_2","first-page":"380","article-title":"Divalproex sodium in the treatment of refractory affective disorders","volume":"54","author":"Schaff MR","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_1_66_2","first-page":"40","article-title":"The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders","volume":"50","author":"Sovner R.","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00008"},{"key":"e_1_2_1_68_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania","volume":"271","author":"Bowden CL","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"e_1_2_1_69_2","first-page":"13","article-title":"U.S. experience with valproate in manic depressive illness: a multicenter trial","volume":"50","author":"Brown R.","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379203700820"},{"key":"e_1_2_1_71_2","first-page":"229","article-title":"Low\u2010dose valproate: a new treatment for cyclothymia, mild rapid\u2010cycling disorders, and premenstrual syndrome","volume":"54","author":"Jacobsen FM.","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_1_72_2","first-page":"35","article-title":"Long\u2010term use of valproate in primary psychiatric disorders","volume":"50","author":"Hayes SG.","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.2.114"},{"key":"e_1_2_1_74_2","first-page":"509","article-title":"Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug\u2010induced tremor","volume":"14","author":"Nagao T.","year":"1979","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.3.240"},{"key":"e_1_2_1_76_2","first-page":"1212","article-title":"Effect of valproic acid on schizophrenic syndromes","volume":"30","author":"Gundurewa V.","year":"1980","journal-title":"Arzneimittel-forschung"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1159\/000118053"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90085-X"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.4.542"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198902000-00010"},{"key":"e_1_2_1_81_2","first-page":"199","article-title":"Treatment of resistant schizophrenia with valproate and neuroleptic drugs","volume":"11","author":"Moringo A.","year":"1989","journal-title":"Hillside J Clin Psychiatry"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199204000-00015"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb01990.x"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379003500309"},{"issue":"3","key":"e_1_2_1_85_2","first-page":"44","article-title":"Valproate in anxiety and withdrawal syndromes","volume":"50","author":"Roy\u2010Byrne PP","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90010-B"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.3.2.232-a"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(91)90091-E"},{"key":"e_1_2_1_89_2","first-page":"81","article-title":"Valproate treatment of comorbid panic disorder and affective disorders in two alcoholic patients [letter]","volume":"14","author":"Brady KT","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_90_2","first-page":"78","article-title":"Sodium valproate and clonazepam for treatment\u2010resistant panic disorder","volume":"17","author":"Ontiveros A.","year":"1992","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_1_91_2","first-page":"134","article-title":"Panic disorder: treatment with valproate","volume":"55","author":"Woodman CL","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90170-5"},{"key":"e_1_2_1_93_2","first-page":"361","article-title":"Valproate in combat\u2010related post\u2010traumatic stress disorder","volume":"52","author":"Fesler FA.","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.8.1086b"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1994.02170020106021"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879300600404"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1994.tb06571.x"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199209000-00013"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00012"},{"key":"e_1_2_1_100_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1542\/peds.86.3.467","article-title":"Valproic acid for the treatment of children with mental retardation and mood symptomatology","volume":"86","author":"Kastner T.","year":"1990","journal-title":"Pediatrics"},{"key":"e_1_2_1_101_2","first-page":"525","article-title":"Valproate in the treatment of temper outbursts [letter]","volume":"51","author":"Giakas WJ","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.7.950a"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.160.1.121"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198910000-00007"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199108000-00011"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198808000-00007"},{"key":"e_1_2_1_107_2","first-page":"411","article-title":"Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia","volume":"52","author":"McElroy SL","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00007"},{"key":"e_1_2_1_109_2","first-page":"61","article-title":"The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate","volume":"18","author":"Dilsaver SC","year":"1993","journal-title":"J Psychiatry Neurosci"},{"issue":"2","key":"e_1_2_1_110_2","first-page":"S62","article-title":"Treatment guidelines for valproate in bipolar and schizoaffective disorders","volume":"38","author":"McElroy SL","year":"1993","journal-title":"Can J Psychiatry"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(88)90035-1"},{"key":"e_1_2_1_112_2","first-page":"127","article-title":"Correlates of antimanic response to valproate","volume":"27","author":"McElroy SL","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199308000-00009"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674377902400407"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(81)90010-9"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790230015002"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290053007"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(93)90014-S"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021803"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1993.tb01343.x"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(93)90005-D"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.44.020193.000351"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00006"},{"key":"e_1_2_1_124_2","first-page":"697","volume-title":"Psychopharmacology: the third generation of progress","author":"Eichelman B.","year":"1987"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230616"},{"key":"e_1_2_1_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(81)80004-4"},{"key":"e_1_2_1_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(83)90012-6"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(93)90049-X"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198508000-00007"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90055-1"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.11.1330"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.7.924"},{"key":"e_1_2_1_133_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1985.tb02613.x"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198224060-00004"},{"key":"e_1_2_1_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30168-0"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90054-X"},{"key":"e_1_2_1_137_2","unstructured":"JanicakPG.The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers."},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.1.123"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199112000-00018"},{"key":"e_1_2_1_140_2","first-page":"228","article-title":"Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases","volume":"50","author":"Saxon AJ","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_141_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198812000-00026"},{"issue":"3","key":"e_1_2_1_142_2","first-page":"3","article-title":"Introduction: emerging perspectives on valproate in affective disorders","volume":"50","author":"Post RM.","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00009"},{"key":"e_1_2_1_144_2","first-page":"305","article-title":"Valproate oral loading in the treatment of acute mania","volume":"54","author":"Keck PE","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_145_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.6.808"},{"key":"e_1_2_1_146_2","first-page":"254","article-title":"Therapeutic levels of valproate for psychosis","volume":"26","author":"Valkenburg C.","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_147_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.151.12.1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"151","author":"American Psychiatric Association.","year":"1994","journal-title":"Am J Psychiatry"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1995.tb02874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1995.tb02874.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:04Z","timestamp":1761052744000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1995.tb02874.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9,10]]},"references-count":146,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1995.tb02874.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1995.tb02874.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9,10]]},"assertion":[{"value":"2012-01-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}